Open-label flexible dosing 8-week trial of aripiprazole in Tourette syndrome

被引：0
|
作者：
Duane, D. [1 ]
Heimburger, G. [1 ]
Flecky, S. [1 ]
Flutie, J. [1 ]
Owen, R. [1 ]
Zebatto, K. [1 ]
机构：
[1] Arizona Dystonia Inst, Scottsdale, AZ USA
来源：
MOVEMENT DISORDERS | 2006年 / 21卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1555 / 1555
页数：1
相关论文
共 50 条
  • [1] Open-label flexible dosing 8-week trial of aripiprazole in Tourette syndrome children/young adults
    Heimburger, GE
    Duane, DD
    [J]. MOVEMENT DISORDERS, 2005, 20 : S165 - S165
  • [2] Open-label flexible dosing 8-week trial of aripiprazole in Tourette syndrome childhood through young adulthood
    Duane, D. D.
    Heimburger, G. E.
    Flecky, S. A.
    Flutie, J. H.
    Owen, R. L.
    Zebatto, K. B.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S694 - S694
  • [3] Acute phase management of schizophrenia with aripiprazole: A 8-week open-label prospective study in korea
    Cho, S.
    Kwon, J. S.
    Youn, T.
    Kang, D. H.
    [J]. SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 425 - 426
  • [4] Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
    Zhao, Jingyuan
    Song, Xueqin
    Ai, Xiaoqing
    Gu, Xiaojing
    Huang, Guangbiao
    Li, Xue
    Pang, Lijuan
    Ding, Minli
    Ding, Shuang
    Lv, Luxian
    [J]. PLOS ONE, 2015, 10 (10):
  • [5] Olanzapine treatment in Tourette syndrome: An open-label trial
    Lin, JJ
    Chang, DC
    [J]. MOVEMENT DISORDERS, 2002, 17 : S339 - S339
  • [6] An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache
    Volpe, Fernando M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (09) : 1449 - +
  • [7] Varenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study
    Philip, Noah S.
    Carpenter, Linda L.
    Tyrka, Audrey R.
    Whiteley, Laura B.
    Price, Lawrence H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (07) : 1026 - 1031
  • [8] Modafinil as therapy for ADHD in children: An 8-week, open-label study
    Swanson, JM
    Biederman, J
    Boellner, SW
    Earl, C
    Lopez, FA
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (04) : 512 - 513
  • [9] CLINICAL AND IMMUNOLOGICAL EFFECTS OF ORNIDAZOLE IN ACTIVE CROHNS-DISEASE - AN 8-WEEK OPEN-LABEL TRIAL
    DHAENS, G
    PEETERS, M
    CEUPPENS, J
    RUTGEERTS, P
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A809 - A809
  • [10] Agomelatine as a Novel Treatment Option in Panic Disorder, Results From an 8-Week Open-Label Trial
    Huijbregts, Klaas M.
    Batelaan, Neeltje M.
    Schonenberg, Judy
    Veen, Gerthe
    van Balkom, Anton J.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 336 - 338
12345